Dabigatran etexilate mesylate is a pharmaceutical raw material used in the manufacturing of anticoagulant compounds. It serves as an intermediate in the production of active pharmaceutical ingredients for blood clot prevention.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 593282-20-3
Dabigatran etexilate mesylate
pharmaceutical raw material
Dabigatran etexilate
pharmaceutical raw material
Ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate
pharmaceutical raw material
Dabigatran impurity P
pharmaceutical intermediate
Dabigatran ethyl ester
pharmaceutical intermediate
FLUOXETINE HYDROCHLORIDE
pharmaceutical raw material
Alizapride hydrochloride
pharmaceutical raw material
Histidine monohydrochloride monohydrate
pharmaceutical raw material
ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid
XETBXHPXHHOLOE-UHFFFAOYSA-N
CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4.CS(=O)(=O)O